-
1
-
-
80051580618
-
Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths
-
Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: the impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin 2011; 61: 212-236.
-
(2011)
CA Cancer J Clin
, vol.61
, pp. 212-236
-
-
Siegel, R.1
Ward, E.2
Brawley, O.3
Jemal, A.4
-
2
-
-
70349140531
-
Outcomes of localized prostate cancer following conservative management
-
Lu-Yao GL, Albertsen PC, Moore DF, Shih W, Lin Y, DiPaola RS et al. Outcomes of localized prostate cancer following conservative management. JAMA 2009; 302: 1202-1209.
-
(2009)
JAMA
, vol.302
, pp. 1202-1209
-
-
Lu-Yao, G.L.1
Albertsen, P.C.2
Moore, D.F.3
Shih, W.4
Lin, Y.5
Dipaola, R.S.6
-
3
-
-
40949147326
-
Quality of life and satisfaction with outcome among prostate-cancer survivors
-
DOI 10.1056/NEJMoa074311
-
Sanda MG, Dunn RL, Michalski J, Sandler HM, Northouse L, Hembroff L et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N Engl J Med 2008; 358: 1250-1261. (Pubitemid 351439226)
-
(2008)
New England Journal of Medicine
, vol.358
, Issue.12
, pp. 1250-1261
-
-
Sanda, M.G.1
Dunn, R.L.2
Michalski, J.3
Sandler, H.M.4
Northouse, L.5
Hembroff, L.6
Lin, X.7
Greenfield, T.K.8
Litwin, M.S.9
Saigal, C.S.10
Mahadevan, A.11
Klein, E.12
Kibel, A.13
Pisters, L.L.14
Kuban, D.15
Kaplan, I.16
Wood, D.17
Ciezki, J.18
Shah, N.19
Wei, J.T.20
more..
-
4
-
-
77649170747
-
The 2010 NCCN clinical practice guidelines in oncology on prostate cancer
-
Mohler JL. The 2010 NCCN clinical practice guidelines in oncology on prostate cancer. J Natl Compr Canc Netw 2010; 8: 145.
-
(2010)
J Natl Compr Canc Netw
, vol.8
, pp. 145
-
-
Mohler, J.L.1
-
5
-
-
34248175743
-
Guideline for the Management of Clinically Localized Prostate Cancer: 2007 Update
-
DOI 10.1016/j.juro.2007.03.003, PII S0022534707005113
-
Thompson I, Thrasher JB, Aus G, Burnett AL, Canby-Hagino ED, Cookson MS et al. Guideline for the management of clinically localized prostate cancer: 2007 update. J Urol 2007; 177: 2106-2131. (Pubitemid 46726449)
-
(2007)
Journal of Urology
, vol.177
, Issue.6
, pp. 2106-2131
-
-
Thompson, I.1
Thrasher, J.B.2
Aus, G.3
Burnett, A.L.4
Canby-Hagino, E.D.5
Cookson, M.S.6
D'Amico, A.V.7
Dmochowski, R.R.8
Eton, D.T.9
Forman, J.D.10
Goldenberg, S.L.11
Hernandez, J.12
Higano, C.S.13
Kraus, S.R.14
Moul, J.W.15
Tangen, C.M.16
-
6
-
-
78649362120
-
EAU guidelines on prostate cancer. Part 1: Screening, diagnosis, and treatment of clinically localised disease
-
Heidenreich A, Bellmunt J, Bolla M, Joniau S, Mason M, Matveev V et al. EAU guidelines on prostate cancer. Part 1: screening, diagnosis, and treatment of clinically localised disease. Eur Urol 2011; 59: 61-71.
-
(2011)
Eur Urol
, vol.59
, pp. 61-71
-
-
Heidenreich, A.1
Bellmunt, J.2
Bolla, M.3
Joniau, S.4
Mason, M.5
Matveev, V.6
-
7
-
-
79955705831
-
Radical prostatectomy versus watchful waiting in early prostate cancer
-
Bill-Axelson A, Holmberg L, Ruutu M, Garmo H, Stark JR, Busch C et al. Radical prostatectomy versus watchful waiting in early prostate cancer. N Engl J Med 2011; 364: 1708-1717.
-
(2011)
N Engl J Med
, vol.364
, pp. 1708-1717
-
-
Bill-Axelson, A.1
Holmberg, L.2
Ruutu, M.3
Garmo, H.4
Stark, J.R.5
Busch, C.6
-
8
-
-
0035915453
-
Factors associated with initial therapy for clinically localized prostate cancer: Prostate cancer outcomes study
-
Harlan LC, Potosky A, Gilliland FD, Hoffman R, Albertsen PC, Hamilton AS et al. Factors associated with initial therapy for clinically localized prostate cancer: prostate cancer outcomes study. J Natl Cancer Inst 2001; 93: 1864-1871. (Pubitemid 34048653)
-
(2001)
Journal of the National Cancer Institute
, vol.93
, Issue.24
, pp. 1864-1871
-
-
Harlan, L.C.1
Potosky, A.2
Gilliland, F.D.3
Hoffman, R.4
Albertsen, P.C.5
Hamilton, A.S.6
Eley, J.W.7
Stanford, J.L.8
Stephenson, R.A.9
-
9
-
-
33745650451
-
Greater influence of age than co-morbidity on primary treatment and complications of prostate cancer patients: An in-depth population-based study
-
DOI 10.1038/sj.pcan.4500868, PII 4500868
-
Houterman S, Janssen-Heijnen ML, Verheij CD, Kil PJ, van den Berg HA, Coebergh JW. Greater influence of age than co-morbidity on primary treatment and complications of prostate cancer patients: an in-depth population-based study. Prostate Cancer Prostatic Dis 2006; 9: 179-184. (Pubitemid 43970968)
-
(2006)
Prostate Cancer and Prostatic Diseases
, vol.9
, Issue.2
, pp. 179-184
-
-
Houterman, S.1
Janssen-Heijnen, M.L.G.2
Verheij, C.D.G.W.3
Kil, P.J.M.4
Van Den Berg, H.A.5
Coebergh, J.W.6
-
10
-
-
39749132273
-
Is there an optimal comorbidity index for prostate cancer?
-
DOI 10.1002/cncr.23269
-
Alibhai SM, Leach M, Tomlinson GA, Krahn MD, Fleshner NE, Naglie G. Is there an optimal comorbidity index for prostate cancer? Cancer 2008; 112: 1043-1050. (Pubitemid 351304588)
-
(2008)
Cancer
, vol.112
, Issue.5
, pp. 1043-1050
-
-
Alibhai, S.M.H.1
Leach, M.2
Tomlinson, G.A.3
Krahn, M.D.4
Fleshner, N.E.5
Naglie, G.6
-
11
-
-
77957579281
-
Predictive and prognostic models in radical prostatectomy candidates: A critical analysis of the literature
-
Lughezzani G, Briganti A, Karakiewicz PI, Kattan MW, Montorsi F, Shariat SF et al. Predictive and prognostic models in radical prostatectomy candidates: a critical analysis of the literature. Eur Urol 2010; 58: 687-700.
-
(2010)
Eur Urol
, vol.58
, pp. 687-700
-
-
Lughezzani, G.1
Briganti, A.2
Karakiewicz, P.I.3
Kattan, M.W.4
Montorsi, F.5
Shariat, S.F.6
-
12
-
-
34548504813
-
A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer
-
DOI 10.1200/JCO.2006.10.3820
-
Walz J, Gallina A, Saad F, Montorsi F, Perrotte P, Shariat SF et al. A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer. J Clin Oncol 2007; 25: 3576-3581. (Pubitemid 47372594)
-
(2007)
Journal of Clinical Oncology
, vol.25
, Issue.24
, pp. 3576-3581
-
-
Walz, J.1
Gallina, A.2
Saad, F.3
Montorsi, F.4
Perrotte, P.5
Shariat, S.F.6
Jeldres, C.7
Graefen, M.8
Benard, F.9
McCormack, M.10
Valiquette, L.11
Karakiewicz, P.I.12
-
13
-
-
1642412636
-
Long-term survival probability in men with clinically localized prostate cancer: A case-control, propensity modeling study stratified by race, age, treatment and comorbidities
-
DOI 10.1097/01.ju.0000117975.40782.95
-
Tewari A, Johnson CC, Divine G, Crawford ED, Gamito EJ, Demers R et al. Longterm survival probability in men with clinically localized prostate cancer: a casecontrol, propensity modeling study stratified by race, age, treatment and comorbidities. J Urol 2004; 171: 1513-1519. (Pubitemid 38365408)
-
(2004)
Journal of Urology
, vol.171
, Issue.4
, pp. 1513-1519
-
-
Tewari, A.1
Johnson, C.C.2
Divine, G.3
Crawford, E.D.4
Gamito, E.J.5
Demers, R.6
Menon, M.7
-
14
-
-
0030297775
-
The CaPSURE database: A methodology for clinical practice and research in prostate cancer
-
DOI 10.1016/S0090-4295(96)00226-9, PII S0090429596002269
-
Lubeck DP, Litwin MS, Henning JM, Stier DM, Mazonson P, Fisk R et al. The CaPSURE database: a methodology for clinical practice and research in prostate cancer. CaPSURE Research Panel. Cancer of the Prostate Strategic Urologic Research Endeavor. Urology 1996; 48: 773-777. (Pubitemid 26398700)
-
(1996)
Urology
, vol.48
, Issue.5
, pp. 773-777
-
-
Lubeck, D.P.1
Litwin, M.S.2
Henning, J.M.3
Stier, D.M.4
Mazonson, P.5
Fisk, R.6
Carroll, P.R.7
-
15
-
-
67449126769
-
Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis
-
Cooperberg MR, Broering JM, Carroll PR. Risk assessment for prostate cancer metastasis and mortality at the time of diagnosis. J Natl Cancer Inst 2009; 101: 878-887.
-
(2009)
J Natl Cancer Inst
, vol.101
, pp. 878-887
-
-
Cooperberg, M.R.1
Broering, J.M.2
Carroll, P.R.3
-
16
-
-
33644591859
-
Comorbidity and primary treatment for localized prostate cancer: Data from CaPSURE
-
Marr PL, Elkin EP, Arredondo SA, Broering JM, DuChane J, Carroll PR. Comorbidity and primary treatment for localized prostate cancer: data from CaPSURE. J Urol 2006; 175: 1326-1331.
-
(2006)
J Urol
, vol.175
, pp. 1326-1331
-
-
Marr, P.L.1
Elkin, E.P.2
Arredondo, S.A.3
Broering, J.M.4
Duchane, J.5
Carroll, P.R.6
-
17
-
-
79952075128
-
Comorbidity and mortality results from a randomized prostate cancer screening trial
-
Crawford ED, Grubb III R, Black A, Andriole Jr GL, Chen MH, Izmirlian G et al. Comorbidity and mortality results from a randomized prostate cancer screening trial. J Clin Oncol 2011; 29: 355-361.
-
(2011)
J Clin Oncol
, vol.29
, pp. 355-361
-
-
Crawford, E.D.1
Grubb Iii, R.2
Black, A.3
Andriole Jr., G.L.4
Chen, M.H.5
Izmirlian, G.6
-
18
-
-
84869206672
-
National Vital Statistics Report (NVSR)
-
US National Center for Health Statistics, 24 April
-
US National Center for Health Statistics. National Vital Statistics Report (NVSR) Deaths: Final Data for 2006. Vol. 67, No. 14, 24 April 2009.
-
(2009)
Deaths: Final Data for 2006
, vol.67
, Issue.14
-
-
-
19
-
-
1542532754
-
A proportional hazards model for the subdistrituion of a competing risk
-
Fine JP, Gray RJ. A proportional hazards model for the subdistrituion of a competing risk. J Am Stat Assoc 1999; 94: 496-509.
-
(1999)
J Am Stat Assoc
, vol.94
, pp. 496-509
-
-
Fine, J.P.1
Gray, R.J.2
-
20
-
-
48349127426
-
External validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment score
-
Zhao KH, Hernandez DJ, Han M, Humphreys EB, Mangold LA, Partin AW. External validation of University of California, San Francisco, Cancer of the Prostate Risk Assessment score. Urology 2008; 72: 396-400.
-
(2008)
Urology
, vol.72
, pp. 396-400
-
-
Zhao, K.H.1
Hernandez, D.J.2
Han, M.3
Humphreys, E.B.4
Mangold, L.A.5
Partin, A.W.6
-
22
-
-
29144465604
-
Predicting life expectancy in men with clinically localized prostate cancer
-
DOI 10.1016/S0022-5347(05)00018-2, PII S0022534705000182
-
Cowen ME, Halasyamani LK, Kattan MW. Predicting life expectancy in men with clinically localized prostate cancer. J Urol 2006; 175: 99-103. (Pubitemid 41797102)
-
(2006)
Journal of Urology
, vol.175
, Issue.1
, pp. 99-103
-
-
Cowen, M.E.1
Halasyamani, L.K.2
Kattan, M.W.3
-
23
-
-
79954428605
-
Impact of comorbidity on survival among men with localized prostate cancer
-
Albertsen PC, Moore DF, Shih W, Lin Y, Li H, Lu-Yao GL. Impact of comorbidity on survival among men with localized prostate cancer. J Clin Oncol 2011; 29: 1335-1341.
-
(2011)
J Clin Oncol
, vol.29
, pp. 1335-1341
-
-
Albertsen, P.C.1
Moore, D.F.2
Shih, W.3
Lin, Y.4
Li, H.5
Lu-Yao, G.L.6
-
24
-
-
80053339922
-
Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: Competing-risks analysis of a large North American population-based cohort
-
Abdollah F, Sun M, Schmitges J, Tian Z, Jeldres C, Briganti A et al. Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: competing-risks analysis of a large North American population-based cohort. Eur Urol 2011; 60: 920-930.
-
(2011)
Eur Urol
, vol.60
, pp. 920-930
-
-
Abdollah, F.1
Sun, M.2
Schmitges, J.3
Tian, Z.4
Jeldres, C.5
Briganti, A.6
-
25
-
-
70349313376
-
Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era
-
Stephenson AJ, Kattan MW, Eastham JA, Bianco Jr FJ, Yossepowitch O, Vickers AJ et al. Prostate cancer-specific mortality after radical prostatectomy for patients treated in the prostate-specific antigen era. J Clin Oncol 2009; 27: 4300-4305.
-
(2009)
J Clin Oncol
, vol.27
, pp. 4300-4305
-
-
Stephenson, A.J.1
Kattan, M.W.2
Eastham, J.A.3
Bianco Jr., F.J.4
Yossepowitch, O.5
Vickers, A.J.6
-
26
-
-
0029044623
-
Selecting a patient characteristics index for the prediction of medical outcomes using administrative claims data
-
Melfi C, Holleman E, Arthur D, Katz B. Selecting a patient characteristics index for the prediction of medical outcomes using administrative claims data. J Clin Epidemiol 1995; 48: 917-926.
-
(1995)
J Clin Epidemiol
, vol.48
, pp. 917-926
-
-
Melfi, C.1
Holleman, E.2
Arthur, D.3
Katz, B.4
-
27
-
-
0030294149
-
Comorbid Illness is Associated with Survival and Length of Hospital Stay in Patients with Chronic Disability: A Prospective Comparison of Three Comorbidity Indices
-
Rochon PA, Katz JN, Morrow LA, McGlinchey-Berroth R, Ahlquist MM, Sarkarati M et al. Comorbid illness is associated with survival and length of hospital stay in patients with chronic disability. A prospective comparison of three comorbidity indices. Med Care 1996; 34: 1093-1101. (Pubitemid 126433208)
-
(1996)
Medical Care
, vol.34
, Issue.11
, pp. 1093-1101
-
-
Rochon, P.A.1
Katz, J.N.2
Morrow, L.A.3
Mcglinchey-Berroth, R.4
Ahlquist, M.M.5
Sarkarati, M.6
Minaker, K.L.7
-
28
-
-
80053920100
-
Comorbidity and competing risks for mortality in men with prostate cancer
-
(E-pub ahead of print)
-
Daskivich TJ, Chamie K, Kwan L, Labo J, Dash A, Greenfield S et al. Comorbidity and competing risks for mortality in men with prostate cancer. Cancer 2011 (E-pub ahead of print).
-
(2011)
Cancer
-
-
Daskivich, T.J.1
Chamie, K.2
Kwan, L.3
Labo, J.4
Dash, A.5
Greenfield, S.6
-
29
-
-
78449267553
-
Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer
-
Cooperberg MR, Vickers AJ, Broering JM, Carroll PR. Comparative risk-adjusted mortality outcomes after primary surgery, radiotherapy, or androgen-deprivation therapy for localized prostate cancer. Cancer 2010; 116: 5226-5234.
-
(2010)
Cancer
, vol.116
, pp. 5226-5234
-
-
Cooperberg, M.R.1
Vickers, A.J.2
Broering, J.M.3
Carroll, P.R.4
-
30
-
-
78650251130
-
A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006
-
Abdollah F, Sun M, Thuret R, Jeldres C, Tian Z, Briganti A et al. A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006. Eur Urol 2011; 59: 88-95.
-
(2011)
Eur Urol
, vol.59
, pp. 88-95
-
-
Abdollah, F.1
Sun, M.2
Thuret, R.3
Jeldres, C.4
Tian, Z.5
Briganti, A.6
-
31
-
-
69249229866
-
Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction
-
Nanda A, Chen MH, Braccioforte MH, Moran BJ, D'Amico AV. Hormonal therapy use for prostate cancer and mortality in men with coronary artery disease-induced congestive heart failure or myocardial infarction. JAMA 2009; 302: 866-873.
-
(2009)
JAMA
, vol.302
, pp. 866-873
-
-
Nanda, A.1
Chen, M.H.2
Braccioforte, M.H.3
Moran, B.J.4
D'Amico, A.V.5
-
33
-
-
77949898163
-
Time trends and local variation in primary treatment of localized prostate cancer
-
Cooperberg MR, Broering JM, Carroll PR. Time trends and local variation in primary treatment of localized prostate cancer. J Clin Oncol 2010; 28: 1117-1123.
-
(2010)
J Clin Oncol
, vol.28
, pp. 1117-1123
-
-
Cooperberg, M.R.1
Broering, J.M.2
Carroll, P.R.3
|